Advancing Supply Chain Resilience in Europe’s O...

By HEOR Staff Writer

April 28, 2026

In an interview with Adrian van den Hoven, Director General of Medicines for Europe, meaningful progress made in 2025 is highlighted, ...
Medical Device Innovation South Africa: Breaking Down Systemic Barriers
Expanding Access to Hormonal IUDs in South Africa through Generic Innovation
Europe Pharmaceutical Access at a Critical Crossroads Amid U.S. Pricing Policies
Economic Impact of Fragmented Care: Tackling Obesity, Diabetes, and Cardiovas...
Conditional Reimbursement in Chronic Pain Rehabilitation: Navigating Evidence...
Advancing Psychedelic Therapy Access for Treatment-Resistant Mental Illness
HIV Prevention Partnerships: Expanding Access to Lenacapavir for Global Impact
Escalating Public Spending: Semaglutide Off-Label Use Sparks €250 Million Fra...
Closing the East-West Divide: Addressing Healthcare Investment Disparities in...
Safeguarding Access: Navigating Pharmaceutical Cost Pressures in Portugal
Inequality-Adjusted ICER: Enhancing Cost-Effectiveness in Health Technology E...
Shift in Portuguese Pediatric Vaccination Policy: Evolving Perspectives on Ri...